GlassScriptPhysician profile
Erika Johnson
NPI 1508216540
$826.52
in general payments reported to CMS, 2019-2025
18 companies · $229 in 2025
The $229 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $62.66 · 2022: $242 · 2023: $222 · 2024: $71.90 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $522.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $148.28 | 2023 | Xifaxan |
| Astrazeneca Pharmaceuticals LP | $135.48 | 2025 | Airsupra, Breztri |
| Philips North America LLC | $116.68 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $55.81 | 2022-2024 | |
| Phadia US INC. | $55.00 | 2022 | |
| Abbvie INC. | $44.39 | 2021-2024 | |
| Bracco Diagnostics INC. | $43.24 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $37.16 | 2024 | Crysvita |
| Cipher Pharmaceuticals US LLC | $33.12 | 2025 | Spinosad, Natroba |
| Novartis Pharmaceuticals Corporation | $22.37 | 2023 | |
| Amarin Pharma, INC. | $22.22 | 2021 | |
| Lundbeck LLC | $20.73 | 2023 | Rexulti |
| Paratek Pharmaceuticals, INC. | $16.69 | 2025 | Nuzyra |
| Abbott Laboratories | $16.08 | 2022 | |
| Lilly USA, LLC | $15.62 | 2023 | Mounjaro |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $15.33 | 2022 | |
| Glaxosmithkline, LLC. | $14.70 | 2022 | |
| Amgen INC. | $13.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erika Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.